TUMOR-INFILTRATING NOCICEPTOR NEURONS PROMOTE IMMUNOSUPPRESSION.
Anthony C RestainoMaryam AhmadiAmin Reza NikpoorAustin WalzMohammad BaloodTuany EichwaldSebastien TalbotPaola Drapkin VermeerPublished in: bioRxiv : the preprint server for biology (2024)
Nociceptor neurons impact tumor immunity. Removing nociceptor neurons reduced myeloid-derived suppressor cell (MDSCs) tumor infiltration in mouse models of head and neck carcinoma and melanoma. Carcinoma-released small extracellular vesicles (sEVs) attract nociceptive nerves to tumors. sEV-deficient tumors fail to develop in mice lacking nociceptor neurons. Exposure of dorsal root ganglia (DRG) neurons to cancer sEVs elevated expression of Substance P, IL-6 and injury-related neuronal markers while treatment with cancer sEVs and cytotoxic CD8 T-cells induced an immunosuppressive state (increased exhaustion ligands and cytokines). Cancer patient sEVs enhanced DRG responses to capsaicin, indicating increased nociceptor sensitivity. Conditioned media from DRG and cancer cell co-cultures promoted expression of MDSC markers in primary bone marrow cells while DRG conditioned media together with cancer sEVs induced checkpoint expression on T-cells. Our findings indicate that nociceptor neurons facilitate CD8+ T cell exhaustion and enhance MDSC infiltration. Targeting nociceptor-released IL-6 emerges as a novel strategy to disrupt harmful neuro-immune interactions in cancer and enhance anti-tumor immunity.
Keyphrases
- papillary thyroid
- spinal cord
- squamous cell
- bone marrow
- long non coding rna
- neuropathic pain
- mouse model
- stem cells
- squamous cell carcinoma
- type diabetes
- binding protein
- mesenchymal stem cells
- childhood cancer
- spinal cord injury
- young adults
- cell proliferation
- induced apoptosis
- single cell
- skeletal muscle
- signaling pathway
- case report
- drug induced
- combination therapy
- anti inflammatory
- blood brain barrier